Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks

Completed · Not applicable

Conditions studied: Abortion

In brief

Women who are requesting pregnancy termination at 14-16 weeks, who would normally have osmotic dilator insertion the day before their procedure, would be asked if they wanted to participate. Participants would be randomized to two groups: first, dilator insertion as usual, or second, mifepristone taken the day before the procedure.

Key facts

Study ID

NCT00986921

Run by

Boston University

People needed

50

Starts

2009-10-01

Expected to finish

2011-03-01

Last updated by the study team

2014-01-31

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• women aged 18-45 having pregnancy termination at 14-16 weeks

You may not qualify if…

• multiple gestation, pre-existing infection, contraindication to osmotic dilators, unable to obtain proper consent

Where it is running

• Boston Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.